METROPOLITAN LIFE INSURANCE CO/NY - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 112 filers reported holding IRADIMED CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$20,632
-7.1%
4650.0%0.00%0.0%
Q2 2023$22,199
+21.3%
4650.0%0.00%0.0%
Q1 2023$18,298
+39.1%
4650.0%0.00%0.0%
Q4 2022$13,155
-5.9%
4650.0%0.00%0.0%
Q3 2022$13,978
-11.4%
4650.0%0.00%0.0%
Q2 2022$15,782
-24.3%
4650.0%0.00%0.0%
Q1 2022$20,851
-75.7%
465
-75.0%
0.00%0.0%
Q4 2021$85,9511,8600.00%
Other shareholders
IRADIMED CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 783,066$30,814,0005.13%
Soleus Capital Management, L.P. 773,694$30,444,8593.15%
RK Capital 335,400$13,197,9902.90%
Capital Impact Advisors, LLC 19,390$762,9970.94%
Ranger Investment Management 205,692$8,093,9800.54%
Bares Capital Management 317,000$12,473,9500.44%
Hillsdale Investment Management Inc. 109,100$4,293,0850.37%
CORNERCAP INVESTMENT COUNSEL INC 37,007$1,456,2250.26%
Riverwater Partners LLC 6,234$245,3080.22%
RICE HALL JAMES & ASSOCIATES, LLC 72,271$2,843,8640.16%
View complete list of IRADIMED CORP shareholders